{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:22:25Z","timestamp":1793712145258,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260292"],"award-info":[{"award-number":["82260292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project of Yunnan Provincial Reproductive and Obstetrics and Gynecology Clinical Medicine Center","award":["2022LCZXKF-SZ16"],"award-info":[{"award-number":["2022LCZXKF-SZ16"]}]},{"name":"Open Project of Yunnan Provincial Reproductive and Obstetrics and Gynecology Clinical Medicine Center","award":["2020LCZXKF-SZ08"],"award-info":[{"award-number":["2020LCZXKF-SZ08"]}]},{"name":"Open Project of Yunnan Provincial Reproductive and Obstetrics and Gynecology Clinical Medicine Center","award":["2021LCZXXF-SZ01"],"award-info":[{"award-number":["2021LCZXXF-SZ01"]}]},{"name":"Open Project of Yunnan Provincial Key Specialty of Gynecology","award":["2022FKZDZK-13"],"award-info":[{"award-number":["2022FKZDZK-13"]}]},{"name":"Yunnan Provincial Reproductive and Obstetrics and Gynecology Clinical Medicine Center","award":["zx2019-01-01"],"award-info":[{"award-number":["zx2019-01-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess the impact of the luteinizing hormone level on ovulation trigger day (LHOTD) on in vitro fertilization (IVF) outcomes in gonadotropin-releasing hormone (GnRH) agonist and antagonist regimens during fresh embryo transfer cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A stepwise, progressive multivariate regression model was introduced to assess the effect of the LHOTD on clinical pregnancy and live birth rates. Mantel\u2012Haenszel stratification analysis was used to examine the association between the LHOTD and clinical outcomes with the antagonist regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The LHOTD had different distributions in the agonist and antagonist regimens. The cycles were assigned into three LHOTD tertile groups. In the agonist regimen, compared with the 1\n                      <jats:sup>st<\/jats:sup>\n                      tertile (T1), in the 2\n                      <jats:sup>nd<\/jats:sup>\n                      (T2) and 3\n                      <jats:sup>rd<\/jats:sup>\n                      (T3) tertiles, the adjusted odds ratios (ORs) (95% confidence intervals [CIs],\n                      <jats:italic>P value<\/jats:italic>\n                      ) were 1.187 (1.047\u20131.345, 0.007) and 1.420 (1.252\u20131.610,\u2009&lt;\u20090.001) for clinical pregnancy, respectively, and 1.149 (1.009\u20131.309, 0.036) and 1.476 (1.296\u20131.681,\u2009&lt;\u20090.001) for live birth. In the antagonist regimen, there was no significant difference in clinical pregnancy and live birth rates among the tertiles. However, in the stratified group of patients aged less than 35\u00a0years, the ORs (95% CIs,\n                      <jats:italic>P value<\/jats:italic>\n                      ) of T2 and T3 were 1.316 (1.051\u20131.648, 0.017) and 1.354 (1.077\u20131.703, 0.009) for clinical pregnancy, respectively, and 1.275 (1.008\u20131.611, 0.043) and1.269 (0.999\u20131.611, 0.051) for live birth. Moreover, there was a discrepancy in the results among the subdivided LHOTD T1 groups adopting the antagonist regimen. Compared with that of the\u2009&lt;\u20091.06 mIU\/mL subgroup, the ORs (95% CIs,\n                      <jats:italic>P value<\/jats:italic>\n                      ) of the\u2009&gt;\u20091.5 mIU\/mL subgroup were 1.693 (1.194\u20132.400, 0.003) for clinical pregnancy and 1.532 (1.057\u20132.220, 0.024) for live birth after eliminating potential confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LHOTD was profoundly suppressed in the agonist regimen, and its level was positively correlated with clinical pregnancy and live birth rates. In contrast, in the flexible antagonist regimen, the LHOTD was significantly higher than that in the agonist regimen and did not correlate with the outcome, except for women in the nonadvanced age group and those with an excessively suppressed LHOTD. Further investigation is required to determine the rationale for these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-023-01110-8","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T09:04:01Z","timestamp":1674810241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["LH level on ovulation trigger day has a different impact on the outcomes of agonist and antagonist regimens during in vitro fertilization"],"prefix":"10.1186","volume":"16","author":[{"given":"Xi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuancheng","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"issue":"4","key":"1110_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.fertnstert.2018.01.003","volume":"109","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, Andersen CY, Bosch E, Buhler K, et al. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018;109(4):644\u201364.","journal-title":"Fertil Steril"},{"issue":"3","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.rbmo.2020.08.035","volume":"42","author":"P Arvis","year":"2021","unstructured":"Arvis P, Massin N, Lehert P. Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study. Reprod Biomed Online. 2021;42(3):546\u201354.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"1110_CR3","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/humrep\/det266","volume":"28","author":"TE Konig","year":"2013","unstructured":"Konig TE, van der Houwen LE, Overbeek A, Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, et al. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF\/ICSI: a randomized controlled multicentre study. Hum Reprod. 2013;28(10):2804\u201312.","journal-title":"Hum Reprod"},{"issue":"11","key":"1110_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0015-0282(16)39309-8","volume":"23","author":"MJ Berger","year":"1972","unstructured":"Berger MJ, Taymor ML, Karam K, Nudemberg F. The relative roles of exogenous and endogenous follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in human follicular maturation and ovulation induction. Fertil Steril. 1972;23(11):783\u201390.","journal-title":"Fertil Steril"},{"issue":"5","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/humupd\/dmt023","volume":"19","author":"B Troppmann","year":"2013","unstructured":"Troppmann B, Kleinau G, Krause G, Gromoll J. Structural and functional plasticity of the luteinizing hormone\/choriogonadotrophin receptor. Hum Reprod Update. 2013;19(5):583\u2013602.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1083\/jcb.119.2.439","volume":"119","author":"BS Suh","year":"1992","unstructured":"Suh BS, Sprengel R, Keren-Tal I, Himmelhoch S, Amsterdam A. Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis. J Cell Biol. 1992;119(2):439\u201350.","journal-title":"J Cell Biol"},{"issue":"1\u20132","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2006.08.016","volume":"269","author":"AJ Ziecik","year":"2007","unstructured":"Ziecik AJ, Kaczmarek MM, Blitek A, Kowalczyk AE, Li X, Rahman NA. Novel biological and possible applicable roles of LH\/hCG receptor. Mol Cell Endocrinol. 2007;269(1\u20132):51\u201360.","journal-title":"Mol Cell Endocrinol"},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1749-6632.1991.tb37919.x","volume":"626","author":"K Gordon","year":"1991","unstructured":"Gordon K, Hodgen GD. GnRH analogues in ovarian stimulation. Ann N Y Acad Sci. 1991;626:238\u201349.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1110_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/0974-1208.142476","volume":"7","author":"P Kumar","year":"2014","unstructured":"Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: Understanding advantages and limitations. J Hum Reprod Sci. 2014;7(3):170\u20134.","journal-title":"J Hum Reprod Sci"},{"issue":"9295","key":"1110_CR10","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","volume":"358","author":"JA Huirne","year":"2001","unstructured":"Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet. 2001;358(9295):1793\u2013803.","journal-title":"Lancet"},{"issue":"1","key":"1110_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02925308","volume":"33","author":"T Johnsson","year":"1992","unstructured":"Johnsson T. A procedure for stepwise regression analysis. Stat Pap. 1992;33(1):21\u20139.","journal-title":"Stat Pap"},{"key":"1110_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","volume":"9","author":"SJ Kuritz","year":"1988","unstructured":"Kuritz SJ, Landis JR, Koch GG. A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health. 1988;9:123\u201360.","journal-title":"Annu Rev Public Health"},{"issue":"5","key":"1110_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","volume":"15","author":"LG Westergaard","year":"2000","unstructured":"Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15(5):1003\u20138.","journal-title":"Hum Reprod"},{"issue":"8","key":"1110_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/humrep\/17.8.2016","volume":"17","author":"P Humaidan","year":"2002","unstructured":"Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod. 2002;17(8):2016\u201321.","journal-title":"Hum Reprod"},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"830567","DOI":"10.3389\/fendo.2022.830567","volume":"13","author":"X Luo","year":"2022","unstructured":"Luo X, Li L, Lin N, Ma R, Li Y, Wu Z. Low endogenous LH on the COS initiation day of a GnRH-agonist regimen increases the risk of early pregnancy loss and adverse ART outcomes. Front Endocrinol (Lausanne). 2022;13:830567.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/humrep\/16.8.1636","volume":"16","author":"J Balasch","year":"2001","unstructured":"Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod. 2001;16(8):1636\u201343.","journal-title":"Hum Reprod"},{"issue":"12","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1093\/humrep\/deg506","volume":"18","author":"J Penarrubia","year":"2003","unstructured":"Penarrubia J, Fabregues F, Creus M, Manau D, Casamitjana R, Guimera M, et al. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod. 2003;18(12):2689\u201397.","journal-title":"Hum Reprod"},{"issue":"3","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0015-0282(00)01745-3","volume":"75","author":"MA Esposito","year":"2001","unstructured":"Esposito MA, Barnhart KT, Coutifaris C, Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril. 2001;75(3):519\u201324.","journal-title":"Fertil Steril"},{"issue":"4544","key":"1110_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.6280278","volume":"216","author":"D Heber","year":"1982","unstructured":"Heber D, Dodson R, Swerdloff RS, Channabasavaiah K, Stewart JM. Pituitary receptor site blockade by a gonadotropin-releasing hormone antagonist in vivo: mechanism of action. Science. 1982;216(4544):420\u20131.","journal-title":"Science"},{"issue":"2","key":"1110_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.fertnstert.2005.09.067","volume":"86","author":"SJ Muasher","year":"2006","unstructured":"Muasher SJ, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization. Fertil Steril. 2006;86(2):267\u201373.","journal-title":"Fertil Steril"},{"issue":"5","key":"1110_CR21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","volume":"9","author":"K Diedrich","year":"1994","unstructured":"Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994;9(5):788\u201391.","journal-title":"Hum Reprod"},{"issue":"4","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","volume":"265","author":"M Ludwig","year":"2001","unstructured":"Ludwig M, Katalinic A, Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Arch Gynecol Obstet. 2001;265(4):175\u201382.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","volume":"281","author":"RD Firouzabadi","year":"2010","unstructured":"Firouzabadi RD, Ahmadi S, Oskouian H, Davar R. Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART. Arch Gynecol Obstet. 2010;281(1):81\u20135.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"1110_CR24","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","volume":"78","author":"E Kolibianakis","year":"2002","unstructured":"Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78(5):1025\u20139.","journal-title":"Fertil Steril"},{"issue":"4","key":"1110_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","volume":"79","author":"EM Kolibianakis","year":"2003","unstructured":"Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, et al. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril. 2003;79(4):873\u201380.","journal-title":"Fertil Steril"},{"issue":"1","key":"1110_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/jhrs.JHRS_96_20","volume":"14","author":"N Singh","year":"2021","unstructured":"Singh N, Mishra N, Dogra Y. Do basal luteinizing hormone and luteinizing hormone\/follicle-stimulating hormone ratio have significance in prognosticating the outcome of in vitro fertilization cycles in polycystic ovary syndrome? J Hum Reprod Sci. 2021;14(1):21\u20137.","journal-title":"J Hum Reprod Sci"},{"issue":"11","key":"1110_CR27","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/humrep\/deh471","volume":"19","author":"EM Kolibianakis","year":"2004","unstructured":"Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, et al. Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod. 2004;19(11):2490\u20136.","journal-title":"Hum Reprod"},{"issue":"4","key":"1110_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rbmo.2009.12.019","volume":"20","author":"K Doody","year":"2010","unstructured":"Doody K, Devroey P, Gordon K, Witjes H, Mannaerts B. LH concentrations do not correlate with pregnancy in rFSH\/GnRH antagonist cycles. Reprod Biomed Online. 2010;20(4):565\u20137.","journal-title":"Reprod Biomed Online"},{"key":"1110_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fendo.2019.00639","volume":"10","author":"A Benmachiche","year":"2019","unstructured":"Benmachiche A, Benbouhedja S, Zoghmar A, Humaidan P. Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF\/ICSI treatment and fresh embryo transfer. Front Endocrinol (Lausanne). 2019;10:639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1110_CR30","first-page":"90","volume":"8","author":"A Ramachandran","year":"2014","unstructured":"Ramachandran A, Jamdade K, Kumar P, Adiga SK, Bhat RG, Ferrao SR. Is there a need for Luteinizing Hormone (LH) estimation in patients undergoing ovarian stimulation with Gonadotropin-Releasing Hormone (GnRH) antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)? J Clin Diagn Res. 2014;8(1):90\u20132.","journal-title":"J Clin Diagn Res"},{"key":"1110_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fendo.2019.00067","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu M, Liu S, Li L, Wang P, Li H, Li Y. LH levels may be used as an indicator for the time of antagonist administration in GnRH antagonist protocols-a proof-of-concept study. Front Endocrinol (Lausanne). 2019;10:67.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1110_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.fertnstert.2011.06.069","volume":"96","author":"AM Propst","year":"2011","unstructured":"Propst AM, Hill MJ, Bates GW, Palumbo M, Van Horne AK, Retzloff MG. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration. Fertil Steril. 2011;96(4):898\u2013904.","journal-title":"Fertil Steril"},{"issue":"11","key":"1110_CR33","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2165\/00003495-200868110-00005","volume":"68","author":"S Dhillon","year":"2008","unstructured":"Dhillon S, Keating GM. Lutropin alfa. Drugs. 2008;68(11):1529\u201340.","journal-title":"Drugs"},{"issue":"4","key":"1110_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1472-6483(10)61991-8","volume":"12","author":"J Balasch","year":"2006","unstructured":"Balasch J, Fabregues F. LH in the follicular phase: neither too high nor too low. Reprod Biomed Online. 2006;12(4):406\u201315.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"1110_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1210\/jcem-29-9-1157","volume":"29","author":"CA Strott","year":"1969","unstructured":"Strott CA, Yoshimi T, Ross GT, Lipsett MB. Ovarian physiology: relationship between plasma LH and steroidogenesis by the follicle and corpus luteum; effect of HCG. J Clin Endocrinol Metab. 1969;29(9):1157\u201367.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1110_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/edrv-7-1-44","volume":"7","author":"MJ Karten","year":"1986","unstructured":"Karten MJ, Rivier JE. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr Rev. 1986;7(1):44\u201366.","journal-title":"Endocr Rev"},{"issue":"1","key":"1110_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/endo.135.1.8013383","volume":"135","author":"SL Li","year":"1994","unstructured":"Li SL, Vuagnat B, Gruaz NM, Eshkol A, Sizonenko PC, Aubert ML. Binding kinetics of the long-acting gonadotropin-releasing hormone (GnRH) antagonist antide to rat pituitary GnRH receptors. Endocrinology. 1994;135(1):45\u201352.","journal-title":"Endocrinology"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01110-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T09:05:59Z","timestamp":1674810359000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01110-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was conducted after the approval by the ethics committee of the First People\u2019s Hospital of Yunnan Province (No. KHLL2020-KY013). Each participant gave a written informed consent form at enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}